Table 4.

Univariate logistic regression analysis of associated factors with the use of antiplatelets and statins for primary prevention

	Antiplatelets		Statins
	Unadjusted OR (95% CI)	P	Unadjusted OR (95% CI)	P
Multimorbidity (≥3 chronic conditions)	3.69 (2.52–5.40)	<0.001	4.24 (3.06–5.88)	<0.001
Age (per year)	1.06 (1.04–1.08)	<0.001	1.06 (1.04–1.07)	<0.001
Female gender	0.47 (0.32–0.68)	<0.001	0.44 (0.33–0.60)	<0.001
Low socio-economic status	0.93 (0.52–1.67)	0.807	1.49 (0.96–2.30)	0.074